← Evidence map

ReviewInternational journal of molecular sciences2017

Natalizumab in Multiple Sclerosis: Long-Term Management.

Marinella Clerico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

34 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28468254